Asım OREM, MD, Prof.
Asım OREM, MD, Prof.
Karadeniz Tecnical University, Medical Faculty, Medical Biochemistry
Verified email at
Cited by
Cited by
Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant–antioxidant system in patients with psoriasis
BV Kural, A Örem, G Çimşit, YE Yandı, M Calapoǧlu
Clinica chimica acta 328 (1-2), 71-82, 2003
Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals …
A González‐Sarrías, R García‐Villalba, M Romo‐Vaquero, C Alasalvar, ...
Molecular nutrition & food research 61 (5), 1600830, 2017
Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients
BV Kural, A Örem, G Çimşit, HA Uydu, YE Yandi, A Alver
Clinica Chimica Acta 332 (1-2), 23-30, 2003
The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between …
MV Selma, A González-Sarrías, J Salas-Salvadó, C Andrés-Lacueva, ...
Clinical Nutrition 37 (3), 897-905, 2018
Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects
A Orem, FB Yucesan, C Orem, B Akcan, BV Kural, C Alasalvar, F Shahidi
Journal of clinical lipidology 7 (2), 123-131, 2013
Prognostic value of red cell distribution width in patients with pulmonary embolism
S Ozsu, Y Abul, S Gunaydin, A Orem, T Ozlu
Clinical and Applied Thrombosis/Hemostasis 20 (4), 365-370, 2014
Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon beta
C Boz, M Ozmenoglu, S Velioglu, K Kilinc, A Orem, Z Alioglu, ...
Clinical neurology and neurosurgery 108 (2), 124-128, 2006
Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes
F Mujgan Sonmez, E Demir, A Orem, S Yildirmis, F Orhan, A Aslan, ...
Journal of child neurology 21 (1), 70-74, 2006
How does colistin-induced nephropathy develop and can it be treated?
G Ozkan, S Ulusoy, A Orem, M Alkanat, S Mungan, E Yulug, FB Yucesan
Antimicrobial agents and chemotherapy 57 (8), 3463-3469, 2013
Decreased nitric oxide production in patients with Behçet’s disease
A Örem, B Vanizor, G Cimşit, E Kıran, O Değer, M Malkoç
Dermatology 198 (1), 33-36, 1999
The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant–antioxidant system in patients with dyslipidemia
BV Kural, C Örem, HA Uydu, A Alver, A Örem
Coronary Artery Disease 15 (5), 277-283, 2004
The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels …
A Örem, YE Yandi, B Vanizor, G Çimşit, HA Uydu, M Malkoç
Clinical Biochemistry 35 (3), 217-224, 2002
Relationship between lipid peroxidation and disease activity in patients with Behçet's disease
A Örem, H Efe, O Deǧer, G Çimşit, HA Uydu, B Vanizor
Journal of dermatological science 16 (1), 11-16, 1997
Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy
G Ozkan, S Ulusoy, A Orem, S Ersoz, M Alkanat, FB Yucesan, K Kaynar, ...
Kidney and Blood Pressure Research 35 (6), 445-453, 2013
Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
C Erem, O Değer, M Bostan, A Orem, M Sönmez, S Ulusoy, M Telatar
Acta cardiologica 54 (2), 77-81, 1999
Hazelnut consumption decreases the susceptibility of LDL to oxidation, plasma oxidized LDL level and increases the ratio of large/small LDL in normolipidemic healthy subjects …
FB Yücesan, A Örem, BV Kural, C Örem, İ Turan
The Anatolian Journal of Cardiology 10 (1), 28, 2010
Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications
B Vanizor, A Örem, SC Karahan, E Kiran, C Erem, R Aliyazicioğlu, ...
Diabetes research and clinical practice 54 (1), 33-39, 2001
Prevalence of metabolic syndrome in patients with mucosal lichen planus: A case–control study
L Baykal, DA Arıca, S Yaylı, A Örem, S Bahadır, E Altun, H Yaman
American journal of clinical dermatology 16, 439-445, 2015
The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status
C Örem, A Örem, HA Uydu, S Çelik, C Erdöl, BV Kural
Coronary artery disease 13 (1), 65-71, 2002
Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood
F Müjgan Aynaci, F Orhan, A Orem, S Yildirmis, Y Gedik
Journal of child neurology 16 (5), 367-369, 2001
The system can't perform the operation now. Try again later.
Articles 1–20